US 12030910
Compounds and methods for the modulation of proteins
granted A61KA61K31/7088
Quick answer
US patent 12030910 (Compounds and methods for the modulation of proteins) held by Ionis Pharmaceuticals, Inc. expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Jul 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/7088